Canada markets close in 4 hours 58 minutes

Nuvo Pharmaceuticals Inc. (MRVFF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
1.1400-0.0600 (-5.00%)
As of 9:30AM EST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
68,481
73,775
69,546
19,998
17,523
Cost of Revenue
21,979
23,309
26,472
8,638
8,115
Gross Profit
46,502
50,466
43,074
11,360
9,408
Operating Expenses
Research Development
-
-
-
0
571
Selling General and Administrative
23,335
21,821
27,636
16,238
7,120
Total Operating Expenses
31,085
30,135
35,992
18,227
7,691
Operating Income or Loss
15,417
20,331
7,082
-6,867
1,717
Interest Expense
10,542
11,925
12,756
-32
-
Total Other Income/Expenses Net
-27,682
-11,867
6,612
495
-292
Income Before Tax
-22,264
-2,977
3,389
-6,340
1,582
Income Tax Expense
1,949
1,152
28
-187
1
Income from Continuing Operations
-24,213
-4,129
3,361
-6,153
1,581
Net Income
-24,213
-4,129
3,361
-6,153
1,581
Net Income available to common shareholders
-24,213
-4,129
3,361
-6,153
1,581
Basic EPS
-
-0.36
0.30
-0.54
0.14
Diluted EPS
-
-0.36
-0.51
-0.54
0.12
Basic Average Shares
-
11,388
11,388
11,443
11,550
Diluted Average Shares
-
11,388
43,457
11,443
11,723
EBITDA
-
18,204
25,691
-3,879
1,975